Inactive Instrument

Calendar Protagonist Therapeutics Inc Nasdaq

Equities

US74366E1029

End-of-day quote Nasdaq
- PTS - Intraday chart for Protagonist Therapeutics Inc

Chart calendar Protagonist Therapeutics Inc

2f05214a89dcbd13383.0nWrm9mP8QWJUBZSt7KzYnichsr1uoXw9JRXixwbwfc.pRTd_-3gi1PzJWEIw-f2FU3O7rm419Gmss4e4itijaPjBvHckf2jVL8FRw~b2fe3d4039e0042ced9c0bdd4ca61c88

Upcoming events on Protagonist Therapeutics Inc

20/06/2024 10:30 pm Annual General Meeting
01/08/2024 Q2 2024 Earnings Release (Projected)
06/11/2024 Q3 2024 Earnings Release (Projected)
18/03/2025 Q4 2024 Earnings Release (Projected)
07/05/2025 Q1 2025 Earnings Release (Projected)

Past events on Protagonist Therapeutics Inc

15/05/2024 12:15 am Capital One Biotech/Biopharma Disruptors Conference - Panel
13/05/2024 11:30 pm Citizens JMP Life Sciences Conference - Fireside Chat
09/05/2024 01:35 am Q1 2024 Earnings Release
28/03/2024 10:30 pm H.C. Wainwright Autoimmune & Inflammatory Disease Virtual Conference
26/03/2024 11:00 pm Napa Valley Biotech Forum
12/03/2024 Jefferies Biotech on the Bay Summit
11/03/2024 American Academy of Dermatology Meeting
28/02/2024 02:35 am Q4 2023 Earnings Release
08/02/2024 07:30 pm Guggenheim Healthcare Talks Biotechnology Conference
01/02/2024 03:00 am Business Update Call
09/01/2024 11:15 pm JPMorgan Healthcare Conference
12/12/2023 12:00 am American Society of Hematology Meeting - Session Name: 634
11/12/2023 07:30 am American Society of Hematology Meeting - Session Name: 634
10/12/2023 07:00 am American Society of Hematology Meeting - Session Name: 113
10/12/2023 12:00 am American Society of Hematology Meeting - Session Name: 904
14/11/2023 02:30 pm Jefferies London Healthcare Conference - Fireside Chat
10/11/2023 12:55 am Truist Securities Healthcare Conference - Panel
07/11/2023 J.P. Morgan Equity Opportunities Forum
06/11/2023 09:40 pm Guggenheim Securities Inflammation & Immunology Conference - Fireside Chat
02/11/2023 09:30 am Q3 2023 Earnings Release

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
0,23
1,74
-86.69%
28,6
25,7
11.45%
27,4
23,2
17.93%
26,6
31,4
-15.46%
60,0
30,0
100%

270

EBITDA
Million USD
Released
Forecast
Spread
0,00
0,00
-
-63,7
-68,7
7.22%
-125
-135
7.38%
0,00
0,00
-
-92,7
-96,0
3.46%

82,0

EBIT
Million USD
Released
Forecast
Spread
-80,5
-81,8
1.55%
-64,5
-65,4
1.29%
-126
-128
1.54%
-131
-125
-5.35%
-93,7
-127
26.5%

80,1

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-77,9
-79,3
1.83%
-64,8
-64,1
-1.11%
-126
-128
2.06%
-127
-127
-0.41%
-79,0
-116
31.76%

95,4

Net income
Million USD
Released
Forecast
Spread
-77,2
-77,9
0.89%
-66,2
-66,2
0.04%
-126
-128
1.93%
-127
-123
-3.53%
-79,0
-115
31.24%

77,3

EPS
USD
Released
Forecast
Spread
-2,98
-3,00
0.6%
-1,92
-1,94
0.84%
-2,71
-2,73
0.78%
-2,60
-2,49
-4.44%
-1,39
-2,02
31.28%

1,15

Announcement Date10/03/2010/03/2128/02/2215/03/2327/02/24-

Quarterly results

Fiscal PeriodDecember 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales
Million USD
Released
Forecast
Spread
25,7
17,1
50.86%
0,86
0,38
124.09%
0,00
0,00
-
0,00
5,00
-
0,00
1,67
-
0,00
0,00
-
0,00
0,00
-
60,0
30,0
100%
255
120
112.46%

6,67


0,83


7,50


0,00


100

EBITDA
Million USD
Released
Forecast
Spread
-20,9
-50,0
58.28%
-41,2
-52,0
20.8%
-32,0
-43,0
25.5%
-36,3
-33,0
-9.88%
-35,8
-37,0
3.32%
-42,1
-37,0
-13.83%
-38,1
-43,0
11.44%
23,3
21,0
10.94%
207
-38,0
643.54%

-44,0


-45,0


-36,0







EBIT
Million USD
Released
Forecast
Spread
-21,1
-27,8
24.07%
-41,4
-46,3
10.55%
-32,3
-43,3
25.35%
-36,5
-29,0
-25.97%
-36,0
-36,3
0.65%
-42,4
-36,5
-15.94%
-38,3
-42,6
9.96%
23,0
-10,1
328.49%
206
36,9
458.72%

-39,8


-46,1


-40,3







Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-20,9
-31,6
33.77%
-41,0
-48,9
16.01%
-31,2
-41,7
25.09%
-34,2
-33,6
-1.71%
-33,7
-33,5
-0.69%
-38,5
-35,0
-9.97%
-34,1
-39,7
14.11%
27,3
-8,04
440.04%
211
114
84.39%

-42,9


-43,3


-29,2







Net income
Million USD
Released
Forecast
Spread
-20,9
-30,4
31.15%
-41,0
-45,9
10.65%
-31,2
-43,0
27.39%
-34,2
-29,4
-16.27%
-33,7
-35,9
6.05%
-38,5
-35,5
-8.2%
-34,1
-40,2
15.17%
27,3
-7,61
459.24%
207
39,3
427.28%

-44,8


-45,0


-37,0







EPS
USD
Released
Forecast
Spread
-0,43
-0,63
31.57%
-0,84
-0,94
10.17%
-0,64
-0,87
26.31%
-0,69
-0,59
-16.49%
-0,67
-0,73
7.78%
-0,68
-0,65
-5.22%
-0,58
-0,69
16.27%
0,44
-0,14
406.9%
3,26
1,19
173.04%

-0,73


-0,73


-0,60


-0,77


0,62

Announcement Date04/05/2204/08/2208/11/2215/03/2304/05/2303/08/2302/11/2327/02/2407/05/24-----
  1. Stock Market
  2. Equities
  3. PTGX Stock
  4. Stock
  5. Calendar Protagonist Therapeutics Inc
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW